Medical Director Explains Latest Developments in Multiple Sclerosis Treatment and Research
Ben Thrower, M.D., discusses MS in 10-minute radio podcast.
Researchers are reporting exciting work under way to develop new treatments for multiple sclerosis (MS). Management of the condition can be divided into three areas: relapse treatment, symptom management and disease modification.
In this 10-minute Shepherd Center Radio podcast, Ben Thrower, M.D., medical director of the Andrew C. Carlos MS Institute at Shepherd Center, discusses a number of clinical trials that are under way at Shepherd Center and elsewhere. This podcast and others are available at shepherd.org/news/radio or can be downloaded as an MP3 file from the link above. A transcript of the interview is also available on the Shepherd Center Radio web page.
In the interview, Dr. Thrower discusses one recent pharmaceutical development -- the U.S. Food and Drug Administration's (FDA) approval of Plegridy™ (peginterferon beta-1a), a new treatment for people with relapsing forms of multiple sclerosis (RMS). Clinical trials show the drug reduces relapses, disability progression and brain lesions.
Dr. Thrower is the medical director of the MS Institute at Shepherd Center. He previously served as the medical director of the Holy Family Multiple Sclerosis Institute in Spokane, Wash. In Spokane, he was the chair of the Inland Northwest Chapter of the NMSS. In 2000, he was awarded the Norm Cohn Hope Chest Award by the National MS Society, recognizing his work with the MS community. In 2005, he was the first physician inductee into the Georgia Chapter of the National MS Society Volunteer Hall of Fame.
Shepherd Center, located in Atlanta, Georgia, is a private, not-for-profit hospital specializing in medical treatment, research and rehabilitation for people with spinal cord injury, brain injury, multiple sclerosis, spine and chronic pain, and other neuromuscular conditions. Founded in 1975, Shepherd Center is ranked by U.S. News & World Report among the top 10 rehabilitation hospitals in the nation. In its more than four decades, Shepherd Center has grown from a six-bed rehabilitation unit to a world-renowned, 152-bed hospital that treats more than 740 inpatients, nearly 280 day program patients and more than 7,100 outpatients each year in more than 46,000 visits.